Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant

Annals of Internal Medicine

Volumn 129, Issue 2, 1998, Pages 89-93

  Margaglione, Maurizio ^c   Brancaccio, Vincenzo ^a   Giuliani, Nicola ^c   D'Andrea, Giovanna ^c   Cappucci, Giuseppe ^c   Iannaccone, Luigi ^a   Vecchione, Gennaro ^c   Grandone, Elvira ^c   Di Minno, Giovanni ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; HYPERCOAGULABILITY; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0031847816     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-2-199807150-00003     Document Type: Article

References (19)

1. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861-6.
2. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-44.
3. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-7.
4. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest. 1994;94:923-7.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703.
6. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, et al. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward - relation to family history and vascular risk factors. Thromb Haemost. 1995;73:579-83.
7. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol. 1996;143:1257-65.
8. Ames PR, Pyke S, Iannaccone L, Brancaccio V. Antiphospholipid antibodies, haemostatic variables and thrombosis - a survey of 144 patients. Thromb Haemost. 1995;73:768-73.
9. Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies - a crucial role for acquired free protein S deficiency. Thromb Haemost. 1996;76:190-4.
10. Koeleman BP, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 1994;84:1031-5.
11. Margaglione M, D'Andrea G, Cappucci G, Grandone E, Giuliani N, Colaizzo D, et al. Detection of factor V Leiden using SSCP [Letter]. Thromb Haemost. 1996;76:814-5.
12. Koeleman BP, van Rumpt D, Halmulyàk K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost. 1995;74:580-3.
13. van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost. 1996;75:417-21.
14. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-4.
15. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-6.
16. Svensson JP, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-22.
17. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-7.
18. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, et al. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995;86:3685-91.
19. Martinelli I, Cattaneo M, Panzeri D, Taioli E, Mannucci PM. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med. 1997; 126:707-11.